Notice of application.
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 17, 2020.
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Start Supplemental Information
In accordance with 21 CFR 1301.33(a), this is notice that on May 6, 2020, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616-3466, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:
|Controlled substance||Drug code||Schedule|
|Gamma Hydroxybutyric Acid||2010||I|
|Opium fluid extract||9620||II|
The company plans to manufacture the above-listed controlled substances in bulk for conversion to other controlled substances and sales to its customers for dosage form development, clinical trials and use in stability qualification studies. No other activities for these drug codes are authorized for this registration.
End Supplemental Information
William T. McDermott,
[FR Doc. 2020-13009 Filed 6-16-20; 8:45 am]
BILLING CODE 4410-09-P